Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

PercPad

Financiado

THE FIRST PERCUTANEOUSLY IMPLANTABLE PADDLE LEAD FOR SPINAL CORD STIMULATION

Worldwide, around 1.5 Billion people suffer from chronic pain. Chronic pain undermines the ability to lead a productive working and social life, and it has significant impacts on the private and public economy. The estimated total... ver más

31/08/2022

WISE SRL

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

WISE SRL No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-08-31

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 6 años

0% 70% 100%

2 Participantes

WISE SRL

2.32M€ | Lider

SKY YIELD

347.30K€ | Participante

Últimas noticias

02-12-2024: AGENCIA-VALENCIANA-D... En las últimas 48 horas el Organismo AGENCIA VALENCIANA D... ha otorgado 1 concesiones

02-12-2024: CDTI En las últimas 48 horas el Organismo CDTI ha otorgado 4 concesiones

01-12-2024: REDES En las últimas 48 horas el Organismo REDES ha otorgado 1337 concesiones

Duración del proyecto: 24 meses Fecha Inicio: 2020-08-06
Fecha Fin: 2022-08-31

Líder del proyecto

WISE SRL

TRL 4-5

Presupuesto del proyecto 3M€

Descripción del proyecto Worldwide, around 1.5 Billion people suffer from chronic pain. Chronic pain undermines the ability to lead a productive working and social life, and it has significant impacts on the private and public economy. The estimated total cost for chronic pain is calculated to reach yearly as much as €455 Billion in the USA, and €300 Billion in Europe. Spinal Cord Stimulation (SCS) is a pain relief technique that consist in delivering current pulses to the spinal cord in order to block the sensation of pain. Basic SCS devices comprise implantable leads that are connected to a pulse generator controlled by a control unit. The leads currently available in the market are rather bulky and rigid, poorly stretchable and usually their implantation requires a complex chirurgical intervention. The Percutaneous Spinal Cord Stimulation Paddle Lead (SCS ExpertTM) proposed by WISE is a foldable lead fit for minimally invasive percutaneous implantation, which can be achieved by neurosurgeons and anesthetists. This innovative product addresses a key market need within the SCS segment of the growing neuromodulation market. The goal of this project (PercPad) is to complete the development of SCS ExpertTM and to prepare the path to introduce it into market by the Q4 2022. PercPad is a solid project that will generate important benefits for our company. Within a 5-year period after the launch, WISE expects cummulative gross profits of €36.2 Million, with a payback period of less than 5 years. We have identified a promising market opportunity, as the global neuromodulation market is projected to attain a value of €6.5 Billion in 2022 by rising at a CAGR of 12.5% from 2017, and our target segment is expected to cover over 1/2 of such market worth. Altogether, this represents a very promising scenario for the deployment of SCS ExpertTM and we envisage a country entry SOM of 1.6% reaching a 15% after 5 years.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores